Cargando…
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients
BACKGROUND: Genetic susceptibility plays an important role in the risk of developing pain in individuals with cancer. As a complex trait, multiple genes underlie this susceptibility. We used gene network analyses to identify novel target genes associated with pain in patients newly diagnosed with sq...
Autores principales: | Reyes-Gibby, Cielito C., Wang, Jian, Silvas, Mary Rose T., Yu, Robert, Yeung, Sai-Ching J., Shete, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752805/ https://www.ncbi.nlm.nih.gov/pubmed/26872611 http://dx.doi.org/10.1186/s12863-016-0348-7 |
Ejemplares similares
-
Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients
por: Reyes-Gibby, Cielito C., et al.
Publicado: (2016) -
Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction
por: Reyes-Gibby, Cielito C., et al.
Publicado: (2015) -
Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer
por: Reyes-Gibby, Cielito C., et al.
Publicado: (2018) -
Informative gene network for chemotherapy-induced peripheral neuropathy
por: Reyes-Gibby, Cielito C., et al.
Publicado: (2015) -
Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors
por: Ren, Jenny L., et al.
Publicado: (2021)